InventisBio Co (SHSE:688382) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688382 InventisBio Co Ltd SHSE:688382
29 GF Score
Price ¥25.99
GF Value ¥10.07
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is InventisBio Co Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

SHSE:688382
29GF Score
InventisBio Co Ltd SHSE:688382
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is InventisBio Co (SHSE:688382) Overvalued in 2026?

Based on GuruFocus' analysis, InventisBio Co stock appears to be overvalued. The current stock price of ¥25.99 is trading 158.1% above its estimated GF Value™ of ¥10.07. GuruFocus considers InventisBio Co to be Significantly Overvalued.

Key valuation signals for SHSE:688382:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ¥10.07 vs. price of ¥25.99 (158.1% above fair value)
  • GF Score™: 29/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688382 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


InventisBio Co Business Description

Address No. 4, Lane 67, Li Bing Road, Room 210, Pilot Free Trade Zone, Shanghai, CHN, 201203
InventisBio Co Ltd is an innovative drug research and development enterprise based in China with a global perspective, focusing on major diseases such as tumors and metabolic diseases. It has independently developed a series of innovative targeted drugs with patent protection, covering non-small cell lung cancer, breast cancer, colorectal cancer and other solid tumors, as well as hyperuricemia and metabolic diseases such as gout.
29GF Score

Get the complete analysis for SHSE:688382

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥25.99
Price
¥10.07
GF Value